![Michael G Natchus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael G Natchus
Geschäftsführer bei Emory Institute For Drug Development
Ursprung des Netzwerks ersten Grades von Michael G Natchus
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Emory Institute For Drug Development
![]() Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael G Natchus
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CHIMERIX, INC. | Pharmaceuticals: Major | Founder | |
Emory University | College/University | Doctorate Degree | |
Koronis Pharmaceuticals, Inc.
![]() Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Drug Innovation Ventures At Emory LLC | Chief Executive Officer | ||
Altesa Biosciences, Inc.
![]() Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Biotechnology | Founder |
Statistik
International
Vereinigte Staaten | 8 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Operativ
Founder | 3 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
President | 2 |
Corporate Officer/Principal | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
George R. Painter | 9 |
- Börse
- Insiders
- Michael G Natchus
- Unternehmensverbindungen